Antidepressant therapy and C-reactive protein levels

The British Journal of Psychiatry : the Journal of Mental Science
Sinead M O'BrienTimothy G Dinan

Abstract

Major depression is associated with activation of the inflammatory response. To examine C-reactive protein levels in depression and to determine the impact of selective serotonin reuptake inhibitor (SSRI) therapy. A two-part study. In study 1, which used a between-subjects design, C-reactive protein was measured in 32 patients (20 currently depressed, 12 euthymic) with a history of DSM-IV major depression, all of whom were treated with an SSRI, and in a healthy comparison group (n = 20). Study 2 employed a within-subject design: C-reactive protein was measured in 20 patients with major depression both before and after SSRI treatment. In study 1, C-reactive protein levels did not differ between the group with depressive disorder (either currently depressed or euthymic) treated with SSRIs and the healthy group. In study 2 the protein levels dropped significantly following treatment with antidepressant medication. Following SSRI treatment for major depression there is a significant drop in C-reactive protein concentrations whether or not the depression resolves. These findings indicate that antidepressants induce an anti-inflammatory response independent of antidepressant action.

References

Jan 1, 1982·Annals of the New York Academy of Sciences·I Kushner
Apr 1, 1993·The Journal of Clinical Investigation·D M VigushinP N Hawkins
Oct 16, 1996·Psychiatry Research·A SluzewskaK Wiktorowicz
Dec 12, 1997·Journal of Psychosomatic Research·M BerkA O'Neill-Kerr
May 9, 1998·Journal of Affective Disorders·M HornigJ D Amsterdam
Mar 26, 1999·BMJ : British Medical Journal·T G Dinan
Aug 12, 1999·Advances in Experimental Medicine and Biology·M Maes
Mar 20, 2001·Archives of General Psychiatry·B W PenninxW van Tilburg
Mar 14, 2001·Journal of Affective Disorders·M RothermundtH Kirchner
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
Mar 13, 2002·Circulation·Johann W AuerBernd Eber
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Apr 9, 2004·The New England Journal of Medicine·John DaneshVilmundur Gudnason
Jan 7, 2005·The New England Journal of Medicine·Steven E NissenUNKNOWN Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators
Sep 30, 1930·The Journal of Experimental Medicine·W S Tillett, T Francis

❮ Previous
Next ❯

Citations

May 2, 2009·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G CizzaUNKNOWN P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group
Jan 6, 2009·Current Opinion in Psychiatry·Timothy G Dinan
Aug 24, 2007·Neuroimmunomodulation·Sinead M O'BrienTimothy G Dinan
Jul 17, 2012·Neuroimmunomodulation·Ehud BaharavAvraham Weizman
Mar 24, 2007·Molecular Medicine·Rahman ShahRobert Soufer
Jul 10, 2010·International Journal of Environmental Research and Public Health·Fatma G HuffmanSubrata Nath
Jul 12, 2012·Journal of Geriatric Cardiology : JGC·Jeong-Hoon Ha, Cheuk-Kit Wong
Jun 28, 2011·Journal of Pharmacology & Pharmacotherapeutics·Nilesh Chavda Jaykaran
Nov 13, 2013·Annual Review of Medicine·M Beatriz Currier, Charles B Nemeroff
Nov 14, 2013·Case Reports in Psychiatry·Shahzad M AlikhanLuiz Dratcu
Feb 26, 2008·European Archives of Psychiatry and Clinical Neuroscience·Angelo B CunhaFlávio Kapczinski
Sep 5, 2015·Journal of Affective Disorders·Jess G FiedorowiczJohn A Wemmie
Aug 16, 2011·Brain, Behavior, and Immunity·Hui Hua ChangPo See Chen
Jun 29, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Lucia CarboniEnrico Domenici
Jan 18, 2016·The International Journal of Neuropsychopharmacology·Martina M HughesAndrew Harkin
Jul 29, 2009·Brain, Behavior, and Immunity·Nancy Frasure-SmithBruce G Pollock
Aug 4, 2009·Neuropeptides·K M HegadorenN Lacaze-Masmonteil
Sep 12, 2009·Brain Research Reviews·Micaela SantosPanteleimon Giannakopoulos
Aug 5, 2008·Trends in Neurosciences·Carmine M Pariante, Stafford L Lightman
Mar 30, 2007·Journal of Psychiatric Research·Sibylle HäfnerClemens von Schacky
Oct 27, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tiao-Lai Huang, Fu-Chen Lin
Jul 15, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R StrawbridgeA J Cleare
Aug 4, 2015·Journal of Diabetes and Its Complications·Zahra YektaPeter P Reese
Feb 20, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Hui Hua ChangPo See Chen
Nov 14, 2008·International Journal of Cardiology·Gillian L Sowden, Jeff C Huffman
Jun 13, 2012·Journal of the Neurological Sciences·Micaela SantosPanteleimon Giannakopoulos
Aug 21, 2012·Neurología : publicación oficial de la Sociedad Española de Neurología·G Espárrago LlorcaM D Jiménez Hernández
Jun 10, 2016·Nature Reviews. Neuroscience·Eric S WohlebRonald S Duman
Jul 28, 2016·Immunobiology·Katarzyna NazimekKrzysztof Bryniarski
Aug 23, 2016·Drug Development Research·Natasa Bogavac-Stanojevic, Dragana Lakic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
S LanquillonH Vedder
Current Opinion in Psychiatry
Timothy G Dinan
© 2022 Meta ULC. All rights reserved